Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05262140 · ClinicalTrials.gov registry record
In Vivo Quantification of Cervical Collar Efficacy
A clinical trial of Spine Injury, sponsored by Methodist Health System.
- Recruiting
- Registry status
- 60
- Enrollment target
- 1
- Study location
NCT05262140: Recruiting study of Spine Injury, sponsored by Methodist Health System.
NCT05262140 is a study of Spine Injury that is actively recruiting participants, run by Methodist Health System. The registered enrollment target is 60 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05262140, a study of Spine Injury, is actively recruiting participants, sponsored by Methodist Health System.
- RECRUITING
- Registry status
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective interventional trial with healthy volunteers at Methodist Dallas Medical Center. We anticipate data collection to be completed by December 2023. All study participants will be consented regardless of their role as healthy C-spine volunteer or provider volunteer (Appendix C). No compensation will be provided. Provider volunteers will be classified as: * Attending * Resident * Physician assistant, nurse practitioner, or nurse * EMS/Paramedic * Other, as determined by job functions in pre-assessment
Conditions Studied
Study Locations (1)
Texas
- Methodist Dallas Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2022-01-19 |
| Est. Completion | 2025-01-19 |
What NCT05262140 shows while recruiting
NCT05262140 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 1 condition, with Spine Injury appearing as the primary indexed condition, and to 0 interventions.
NCT05262140 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05262140 about?
NCT05262140 is a clinical study titled "In Vivo Quantification of Cervical Collar Efficacy". This is a prospective interventional trial with healthy volunteers at Methodist Dallas Medical Center. We anticipate data collection to be completed by December 2023. All study participants will be consented regardless of their role as healthy C-spine volunteer or provider volunteer (Appendix C). No...
What is the current status of trial NCT05262140?
This trial is currently recruiting. The enrollment target is 60 participants. The study started on 2022-01-19. Estimated completion is 2025-01-19.
What conditions does trial NCT05262140 study?
This clinical trial studies the following conditions: Spine Injury.
Who is sponsoring clinical trial NCT05262140?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05262140 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI